Bigora Sian 4

What Happened
Bigora Sian, Chief Development Officer of Processa Pharmaceuticals (PCSA), purchased 2,107 shares on March 31, 2026 at $2.54 per share for a total cost of $5,341. The Form 4 classifies the transaction as a purchase (code P) and describes it as an "open market or private purchase."

Key Details

• Transaction date: 2026-03-31; Form 4 filed: 2026-04-01 (filed timely).
• Price: $2.54 per share; Total value: $5,341.
• Shares acquired: 2,107.
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes/plan: No 10b5-1 plan, tax-withholding, or other footnotes noted in the reported transaction.
• Timeliness: No late filing indicator (not marked 'L') — reported within the normal Form 4 window.

Context
This was a straightforward share purchase (not an option exercise, award, or gift). The dollar amount is relatively small, so while purchases can be informative, this single modest buy should be weighed along with other insider activity and company developments rather than taken alone as a strong signal.